Advertisements

Stocking Stuffers

 

Critical Outcome Technologies Inc. (COT:CA) Stock Quote

Detailed Quote for Cotinga Pharmaceuticals Inc (COT:CA)
$ 0.06 0.00 (0.00%) Volume: 0 2:28 PM EST Dec 5, 2019
Today 5d 1m 3m 1y more
Last Price
0.06
Change $
Change %
Tick
  
Bid
0.065
Bid Size
14,000
Ask
0.09
Ask Size
7,000
Open
N/A
High
N/A
Low
N/A
Prev Close
0.06
Last Trade
12/05/19
Volume
0
52 Wk Hi
0.370000004
52 Wk Low
0.05
Market Cap
1.32m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
16,686,968
EPS (TTM)
-0.090000003
PE Ratio
N/A
Exchange
TSXV
News and Media for Cotinga Pharmaceuticals Inc (COT:CA)
Sector News | Topic News
News for Cotinga Pharmaceuticals Inc (COT:CA)
Thu, Nov 07, 2019
4:09 PM IIROC Trading Resumption - COT - Canada Newswire
Mon, Oct 07, 2019
8:12 AM IIROC Trading Halt - COT - Canada Newswire
Thu, Jul 18, 2019
12:40 PM Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors - GlobeNewswire
Thu, Jun 27, 2019
12:18 PM Cotinga Pharmaceuticals Doses First Patient in Third Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors - GlobeNewswire
Wed, Jun 05, 2019
12:42 PM Cotinga Pharmaceuticals Announces Initiation of Next Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors - GlobeNewswire
Tue, Jun 04, 2019
6:01 PM Cotinga Pharmacueticals Announces Closing of Second Tranche of Unit Offering - GlobeNewswire
Wed, May 22, 2019
5:26 PM Cotinga Pharmacueticals Announces Closing of Unit Offering - GlobeNewswire
Wed, May 08, 2019
11:10 AM Cotinga Pharmaceuticals Releases Early Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors - GlobeNewswire
Fri, Apr 05, 2019
1:18 PM Cotinga Pharmaceuticals Reports Fiscal 2019 Third Quarter\u00A0Financial and Operating Results - GlobeNewswire
Tue, Mar 19, 2019
11:00 AM Cotinga Pharmacueticals Provides Scientific and Business Update at Annual General Meeting and Announces Unit Offering - GlobeNewswire
Tue, Feb 26, 2019
11:08 AM Cotinga Pharmaceuticals Doses First Patient in Second Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors - GlobeNewswire
Tue, Jan 29, 2019
10:21 AM Cotinga Pharmaceuticals Doses Cohort 1 Patients With Combination Therapy in Phase 1b/2a Trial of COTI-2 - GlobeNewswire
Tue, Jan 15, 2019
8:00 AM Cotinga Pharmaceuticals Doses First Patient With Combination Therapy in Phase 1b/2a Trial of COTI-2 - GlobeNewswire
7:45 AM Today's Research Reports on Cotinga Pharmaceuticals, Aurinia Pharmaceuticals, Resverlogix and Hamilton Thorne - ACCESSWIRE IA
Tue, Jan 08, 2019
12:20 PM Cotinga Pharmaceuticals Enrolls Two Patients for Combination Therapy in Phase 1b/2a Trial of COTI-2 - GlobeNewswire
Thu, Jan 03, 2019
12:32 PM Cotinga Pharmaceuticals Reports Fiscal 2019 Second Quarter Financial and Operating Results - GlobeNewswire
Thu, Nov 29, 2018
7:50 AM Today's Research Reports on Sernova, Covalon Technologies, CRH Medical and Cotinga Pharmaceuticals - ACCESSWIRE IA
Mon, Nov 05, 2018
8:00 AM Cotinga Pharmaceuticals Announces Research Partnership with St. Vincent's University Hospital to Evaluate COTI-2 - GlobeNewswire
Tue, Oct 30, 2018
8:00 AM Today's Research Reports on Fennec Pharmaceuticals, Baylin Technologies, CRH Medical and Cotinga Pharmaceuticals - ACCESSWIRE IA
Tue, Oct 02, 2018
8:00 AM Cotinga Pharmaceuticals Reports Fiscal 2019 First Quarter Financial and Operating Results - GlobeNewswire
More News for COT:CA >>

Tags for Critical Outcome Technologies Inc.

Research stocks or mutual funds related to Critical Outcome Technologies Inc. by keywords or tags. Find companies that have a similar focus to COT:CA. The keywords below have been associated to COT:CA by either user submission or electronic means.

Pharmaceutical and Medicine Manufacturing (325410) Drugs Pharmaceutical and Medicine Industry (3741) Healthcare Common Stock